Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Chronic Lymphocytic Leukemia
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Biological, Drug
Participants:
63
Start Date:
December 31, 2021
A Phase 2 Trial of the Combination of Polatuzumab Vedotin, Venetoclax and Rituximab and Hyaluronidase Human for Relapsed and Refractory Mantle Cell Lymphoma
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Procedure, Device, Drug
Participants:
200
Start Date:
December 1, 2021
A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Hematologic Malignancies
Search for trials
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Biological, Drug
Participants:
122
Start Date:
July 30, 2021
An Open-Label Phase 1/2 Multi-Arm Study of DS-1594b as a Single-Agent and in Combination With Azacitidine and Venetoclax or Mini-HCVD for the Treatment of Patients With Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL)
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Drug, Biological
Participants:
50
Start Date:
June 30, 2021
Ipilimumab Combined With Ibrutinib and Nivolumab for Patients With Chronic Lymphocytic Leukemia (CLL) and Richter Transformation (RT)
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
22
Start Date:
June 30, 2021
A Phase 2 Trial of Acalabrutinib for the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Other, Drug
Participants:
134
Start Date:
June 30, 2021
A Prospective Study of Patients With B-Cell Hematologic Malignancies on Ibrutinib Therapy Who Are Infected With Coronavirus Disease 2019 (COVID-19)
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Other, Drug, Radiation, Procedure, Biological
Participants:
240
Start Date:
June 1, 2021
A Randomized Phase II Study to Compare ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Device
Participants:
46
Start Date:
May 3, 2021
Neuromuscular Electrical Stimulation for Physical Function Maintenance During Hematopoietic Stem Cell Transplantation
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Drug, Biological
Participants:
20
Start Date:
May 1, 2021
A Phase 1 Single-Center Trial Combining Venetoclax With G-CSF, Cladribine, Cytarabine, and Mitoxantrone (CLAG-M) for Patients With AML and High-Grade Myeloid Neoplasms
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug, Procedure
Participants:
25
Start Date:
May 1, 2021
A Phase II Study of a Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia (ALL) Incorporating Inotuzumab Ozogamicin (InO)
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
55
Start Date:
April 30, 2021
Venetoclax and Delayed Rituximab With Ibrutinib Consolidation Aiming at Undetectable Minimal Residual Disease (uMRD) in Treatment-naïve Patients With Chronic Lymphocytic Leukemia (CLL)
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
60
Start Date:
April 2021
A Phase 2 Study of Acalabrutinib, Umbralisib, and Ublituximab (AU2) in Relapsed and Previously Untreated CLL Patients
Showing 1-12 of 457
Next